Research Alliance CORP Iii Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Oak Hill Bio merges with Research Alliance Corporation III (SPAC) to fund its Angelman syndrome drug development, aiming for Nasdaq listing.
NASDAQ
Research Alliance Corporation III (RACC) has entered into a definitive business combination agreement with OHB Pediatrics Ltd. (Oak Hill Bio) to form a new publicly traded rare disease biotechnology company.